KLDO (KLDO) Stock Price & Analysis
KLDO (KLDO) rose 0.00% to USD 0 as of June 10, 2026 at 00:46 UTC, according to Nexqual real-time market data.
KLDO last closed at USD 0; the session ranged USD 0–0 on volume of 1,055 shares. Market capitalization is $4,262, with a 52-week range of USD 0–0.19 (PNK). Source: Nexqual, June 10, 2026 at 00:46 UTC.
Key Statistics (as of June 10, 2026 at 00:46 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.19 |
| Volume | 1,055 shares |
| Market Cap | $4,262 |
| Exchange | PNK |
Technical Analysis (KLDO)
Nexqual's technical model rates KLDO "SELL" based on 1 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 00:46 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.97 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (KLDO)
Wall Street analysts rate KLDO "None", per Nexqual as of June 10, 2026 at 00:46 UTC.
| Consensus Rating | None |
|---|
Earnings (KLDO)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2021-12-31 | USD -0.48 vs est -0.58 ▲ beat |
| 2021-09-30 | USD -0.54 vs est -0.54 ▼ miss |
| 2021-06-30 | USD -0.56 vs est -0.58 ▲ beat |
| 2021-03-31 | USD -0.58 vs est -0.6 ▲ beat |
Source: Nexqual, June 10, 2026 at 00:46 UTC.
Financials & Fundamentals (KLDO)
| Total Revenue | $1.10M |
|---|---|
| Revenue Growth (YoY) | +102.50% |
| Gross Margin | +0.00% |
| Operating Margin | -3974.39% |
| Profit Margin | +0.00% |
| ROE | -580.57% |
| Debt / Equity | 204.53 |
| Current Ratio | 1.43 |
| Total Cash | $38.47M |
| Total Debt | $21.69M |
| Free Cash Flow | $-46.02M |
Source: Nexqual, June 10, 2026 at 00:46 UTC.
Financial Health Score (KLDO)
Nexqual rates KLDO's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 00:46 UTC.
| Growth | Solid — Revenue +13% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Weak — $38M cash vs $22M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$46M, burning cash |
| Efficiency | Critical — ROE -581%, ROA -99.9% |
Ownership (KLDO)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.03% |
| Shares Outstanding | 42.62M |
| Float | 42.45M |
| Short % of Float | +14.19% |
Source: Nexqual, June 10, 2026 at 00:46 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DTIL | Precision BioSciences, Inc. | USD 6.86 | ▲ 5.54% |
| LOGC | ContextLogic Holdings Inc. | USD 9.75 | ▲ 6.56% |
| ALEC | Alector, Inc. | USD 1.63 | ▼ 0.31% |
| EVLO | Evelo Biosciences, Inc. | USD 0 | ▲ 0% |
| GOSS | Gossamer Bio, Inc. | USD 0.16 | ▼ 8.57% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:46 UTC. This page is informational and not investment advice.